{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:00Z","timestamp":1786119540373,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Medical and Health Project in Zhejiang Province","award":["2023KY1043"],"award-info":[{"award-number":["2023KY1043"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"abstract":"<jats:p>\n                    The objective of this study is to investigate the involvement of creatine phosphate (CP) in sepsis-induced myocardial dysfunction (SIMD) among patients. A retrospective analysis was conducted to gather data on patients with SIMD. Based on the administration of CP, the patients were categorized into 2 groups: the observation group and the control group. The study recorded fundamental demographic information including age, gender, and factors contributing to infection, as well as various clinical indices. Additionally, measurements of vasoactive infusion score (VIS), lactate, N-terminal pro-B-type natriuretic peptide (NT-proBNP), cardiac troponin-I (cTnI), central venous-arterial CO\n                    <jats:sub>2<\/jats:sub>\n                    gap (GAP), and central venous-arterial CO\n                    <jats:sub>2<\/jats:sub>\n                    gap to arterial-central venous O\n                    <jats:sub>2<\/jats:sub>\n                    content difference ratio (Pv-aCO\n                    <jats:sub>2<\/jats:sub>\n                    \/Ca-vO\n                    <jats:sub>2<\/jats:sub>\n                    ) (GAP ratio) were taken before treatment, as well as at 24-hour and 72-hour intervals post-treatment. Furthermore, the study documented the patients\u2019 28-day survival rate, tracheal intubation extubation rate, duration of mechanical ventilation, length of stay in the intensive care unit (ICU), and overall length of hospitalization. A total of 572 patients were ultimately selected for inclusion in the study, with 299 cases assigned to the observation group and 273 cases assigned to the control group. No statistically significant differences were observed between the 2 groups in terms of age, gender, cause of infection, body mass index, cardiac index, Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation II, and premedication clinical indices. After 24 hours of treatment, there were no statistically significant differences between the 2 groups in VIS, lactic acid, cTnI, and GAP ratio, but significant differences were observed in NT-proBNP and GAP. At the 72-hour mark following treatment, the observation group exhibited superior results in VIS, lactate, NT-proBNP, GAP, and GAP ratio compared to the control group. However, there was no statistically significant difference in cTnI levels. Furthermore, the observation group demonstrated significant improvements in the 28-day survival rate, tracheal intubation extubation rate, mechanical ventilation, and ICU stay time, and 28-day all-cause mortality risk Kaplan\u2013Meier curve when compared to the control group. The sustained administration of CP for a duration exceeding 3 days has been observed to enhance the oxygen delivery and systemic perfusion in patients with SIMD, leading to improved cardiac function and cardioprotection. Additionally, this intervention has demonstrated the potential to enhance the patient\u2019s 28-day survival rate, tracheal intubation extubation rate, while reducing the need for mechanical ventilation and length of stay in ICU.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043253","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T16:01:44Z","timestamp":1751904104000},"page":"e43253","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the therapeutic effects of creatine phosphate administration in sepsis-induced myocardial dysfunction"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0590-698X","authenticated-orcid":false,"given":"Linhui","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Intensive Care Unit, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-7991","authenticated-orcid":false,"given":"Gongjie","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250707","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R2-20250707","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11886-020-01277-2","article-title":"Sepsis-induced cardiomyopathy: a comprehensive review.","volume":"22","author":"L\u2019Heureux","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"R3-20250707","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.jvca.2010.11.026","article-title":"Myocardial dysfunction in severe sepsis and septic shock: more questions than answers?","volume":"25","author":"Hochstadt","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R4-20250707","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2321-3868.123072","article-title":"Inflammation and cardiac dysfunction during sepsis, muscular dystrophy, and myocarditis.","volume":"1","author":"Li","year":"2013","journal-title":"Burns Trauma"},{"key":"R5-20250707","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/09674845.2015.11665753","article-title":"Low serum creatine kinase activity in hospital patients.","volume":"72","author":"Cobbold","year":"2015","journal-title":"Br J Biomed Sci"},{"key":"R6-20250707","first-page":"1234","article-title":"Effects of sodium creatine phosphate on VEGF, IL-6, TNF-\u03b1 levels and cardiac function in patients with heart failure and pulmonary infection.","volume":"30","author":"Chen","year":"2020","journal-title":"Chin J Nosocomiol"},{"key":"R7-20250707","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock.","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R8-20250707","first-page":"618","article-title":"Creatine phosphate on severe sepsis patients with myocardial injury.","volume":"44","author":"Ke-qi","year":"2013","journal-title":"New Med"},{"key":"R9-20250707","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/MAT.0000000000001684","article-title":"Comprehensive monitoring in patients with dual lumen right atrium to pulmonary artery right ventricular assist device.","volume":"68","author":"Usman","year":"2022","journal-title":"ASAIO J"},{"key":"R10-20250707","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13613-018-0459-6","article-title":"Development and performance of a novel vasopressor-driven mortality prediction model in septic shock.","volume":"8","author":"Vallabhajosyula","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R11-20250707","first-page":"582","article-title":"The predictive value of vasoactive-inotropic score at different time points in the risk of death in patients with septic shock.","volume":"30","author":"Li","year":"2021","journal-title":"Chin J Emerg Med"},{"key":"R12-20250707","doi-asserted-by":"crossref","first-page":"110385","DOI":"10.1016\/j.jpsychores.2021.110385","article-title":"Associations between NT-proBNP and psychosocial factors in patients with chronic systolic heart failure.","volume":"143","author":"M\u00fcller-Tasch","year":"2021","journal-title":"J Psychosom Res"},{"key":"R13-20250707","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5492\/wjccm.v5.i1.47","article-title":"Use of venous-to-arterial carbon dioxide tension difference to guide resuscitation therapy in septic shock.","volume":"5","author":"Mallat","year":"2016","journal-title":"World J Crit Care Med"},{"key":"R14-20250707","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1164\/rccm.200305-702OC","article-title":"A mathematical model of tissue-blood carbon dioxide exchange during hypoxia.","volume":"169","author":"Gutierrez","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20250707","first-page":"5","article-title":"Clinical application progress of the P (v-a)CO_2\/C (a-v)O_2 ratio in resuscitation of circulatory shock.","volume":"4","author":"Huaiwu","year":"2018","journal-title":"Chin Electron J Crit Care Med"},{"key":"R16-20250707","first-page":"324","article-title":"A myocardial protective agent: phosphocreatine.","volume":"30","author":"Hou","year":"2003","journal-title":"Prog Biochem Biophys"},{"key":"R17-20250707","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fphys.2018.00726","article-title":"Cellular mechanisms of myocardial depression in porcine septic shock.","volume":"9","author":"Jarkovska","year":"2018","journal-title":"Front Physiol"},{"key":"R18-20250707","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1177\/0300060518765896","article-title":"The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy.","volume":"46","author":"Pan","year":"2018","journal-title":"J Int Med Res"},{"key":"R19-20250707","doi-asserted-by":"crossref","first-page":"e0263","DOI":"10.1097\/MD.0000000000010263","article-title":"Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: a comparative retrospective study.","volume":"97","author":"Jeong","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R20-20250707","first-page":"433","article-title":"Early prognostic value of endothelial progenitor cells from human peripheral blood in patients with septic shock.","volume":"34","author":"Pan","year":"2022","journal-title":"Mod Pract Med"},{"key":"R21-20250707","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s10753-020-01233-w","article-title":"Sepsis-induced myocardial dysfunction (SIMD): the pathophysiological mechanisms and therapeutic strategies targeting mitochondria.","volume":"43","author":"Lin","year":"2020","journal-title":"Inflammation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:31:00Z","timestamp":1786041060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":21,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043253","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}